Company: RPTX
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0000950170-25-070351
Chunk: 1

Company: Repare Therapeutics Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Item 1
Chunk 1
---
4; 42,891,403 and 42,510,708 shares   issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

     489,836

     486,674

     Warrants

     27

     10

     Additional paid-in capital

     83,066

     82,191

     Accumulated other comprehensive income

     9

     54

     Accumulated deficit

     (447,841
     )

     (417,798
     )

     Total shareholders’ equity

     125,097

     151,131

     TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
      
     $
     144,023

     $
     176,506

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements